| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.099 | 0.06 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.06 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.08 | 0.07 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |